There is substantial evidence implicating mitochondrial dysfunction and free radical generation in the neurotoxicity of MPTP. Manganese superoxide dismutase (MnSOD) is the primary antioxidant enzyme protecting against superoxide radicals produced within mitochondria. Overexpression of human MnSOD in transgenic mice resulted in increased MnSOD localized to mitochondria in neurons and a 50% increase in total MnSOD activity in brain homogenates. We found that MPTP toxicity was significantly attenuated in the MnSOD transgenic mice which overexpress the human manganese superoxide dismutase gene, with these mice showing threefold greater dopamine levels than controls following MPTP. There were no alterations in MPP ؉ levels, suggesting that the effects were not due to altered metabolism of MPTP. A significant increase in 3-nitrotyrosine levels was seen in littermate controls but not in transgenic mice overexpressing human MnSOD. These results provide further evidence implicating mitochondrial dysfunction and oxidative damage in the pathogenesis of MPTP neurotoxicity. 1998 Academic Press
Mitochondria consume over 90% of the cell's oxygen, and the mitochondrial respiratory chain is a major source of superoxide radicals (Boveris & Chance, 1973) . Several different superoxide dismutases (SOD) have evolved to inactivate both intracellular and extracellular superoxide. The intracellular superoxide dismutases consist of MnSOD, which is localized within the mitochondrial matrix, and copper-and zinccontaining SOD, localized predominantly in cytoplasmic and nuclear compartments (Weisiger & Fridovich, 1973; Beyer et al., 1991) . Another copper-and zinccontaining superoxide dismutase was found predominantly in extracellular compartments (Marklund, 1982) . MnSOD plays a critical role in normal antioxidant function since mice which are deficient develop neurodegeneration, myocardial injury, and perinatal death (Li et al., 1995; Lebovitz et al., 1996) . Furthermore mice with a partial deficiency of MnSOD show increased superoxide radical levels and neuronal degeneration after a permanent focal stroke (Murakami et al., 1998) .
There is substantial evidence that MPTP toxicity involves impairment of mitochondrial function (Tipton & Singer, 1993) . MPTP is metabolized by monoamine oxidase B to 1-methyl-4-phenylpyridinium (MPP ϩ ). MPP ϩ once formed is taken up into dopaminergic neurons by the synaptic dopamine transporter. MPP ϩ then accumulates in mitochondria where it inhibits complex I of the electron transport chain. This may then lead to a pathologic cascade involving both excitotoxicity and free radical generation (Sriram et al., 1997; Hasegawa et al., 1990) .
If the mitochondria are the primary source of superoxide radical generated by MPTP then one would expect that mice overexpressing the MnSOD would show an attenuation of neurotoxicity. In the present study we examined whether mice overexpressing the
